News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
772,376 Results
Type
Article (51861)
Company Profile (296)
Press Release (720205)
Multimedia
Podcasts (115)
Webinars (20)
Section
Business (213233)
Career Advice (2152)
Deals (36779)
Drug Delivery (141)
Drug Development (84239)
Employer Resources (174)
FDA (17367)
Job Trends (15863)
News (361461)
Policy (34958)
Tag
2027 BioCapital Elite (1)
2027 BioCapital Standard (1)
2027 BioMidwest Elite (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (1)
2027 Biotech Beach Standard (1)
2027 Genetown Elite (3)
2027 Genetown Standard (2)
2027 Pharm Country Elite (2)
2027 Pharm Country Standard (5)
Academia (2833)
Accelerated approval (54)
ADA (44)
Adcomms (32)
Allergies (190)
Alliances (51803)
ALS (228)
Alzheimer's disease (1886)
Antibody-drug conjugate (ADC) (509)
Approvals (17795)
Artificial intelligence (743)
ASCO (334)
Autoimmune disease (341)
Automation (60)
Bankruptcy (375)
Best Places to Work (12097)
BIOSECURE Act (20)
Biosimilars (232)
Biotechnology (186)
Bladder cancer (203)
Brain cancer (78)
Breast cancer (809)
Cancer (6300)
Cardiovascular disease (514)
Career advice (1834)
Career pathing (47)
CAR-T (355)
CDC (65)
Celiac Disease (3)
Cell therapy (956)
Cervical cancer (54)
Clinical research (73372)
Collaboration (2225)
Company closure (5)
Compensation (1472)
Complete response letters (86)
COVID-19 (2883)
CRISPR (114)
C-suite (1235)
Cystic fibrosis (156)
Data (8554)
Decentralized trials (3)
Denatured (41)
Depression (178)
Dermatology (96)
Diabetes (663)
Diagnostics (7236)
Digital health (65)
Diversity (14)
Diversity, equity & inclusion (46)
Drug discovery (344)
Drug pricing (212)
Drug shortages (34)
Duchenne muscular dystrophy (299)
Earnings (94478)
Editorial (71)
Employer branding (21)
Employer resources (153)
Events (125707)
Executive appointments (1136)
FDA (21358)
Fibrodysplasia Ossificans Progressiva (8)
Friedreich's ataxia (19)
Frontotemporal dementia (36)
Funding (1846)
Gene editing (245)
Generative AI (68)
Gene therapy (753)
GLP-1 (1156)
Government (5040)
Grass and pollen (6)
Guidances (418)
Healthcare (20241)
Hematology (194)
HIV (89)
Huntington's disease (59)
Idiopathic pulmonary fibrosis (1)
IgA nephropathy (110)
Immunology and inflammation (301)
Immuno-oncology (105)
Indications (205)
Infectious disease (3255)
Inflammatory bowel disease (228)
Inflation Reduction Act (14)
Influenza (141)
Intellectual property (313)
Interviews (338)
IPO (17046)
IRA (51)
Job creations (4069)
Job search strategy (1524)
JPM (58)
Kidney cancer (20)
Labor market (109)
Layoffs (592)
Leadership (43)
Legal (8521)
Liver cancer (107)
Longevity (35)
Lung cancer (845)
Lymphoma (462)
Machine learning (63)
Management (59)
Manufacturing (1126)
MASH (213)
Medical device (15019)
Medtech (15178)
Mergers & acquisitions (21037)
Metabolic disorders (1675)
mRNA (233)
Multiple sclerosis (196)
NASH (17)
Neurodegenerative disease (463)
Neuropsychiatric disorders (112)
Neuroscience (3528)
Neurotech (1)
NextGen: Class of 2026 (6927)
Non-profit (4802)
Now hiring (79)
Obesity (781)
Opinion (312)
Ovarian cancer (238)
Pain (270)
Pancreatic cancer (342)
Parkinson's disease (397)
Partnered (34)
Patents (626)
Patient recruitment (749)
Peanut (67)
People (62770)
Pharmaceutical (65)
Pharmacy benefit managers (34)
Phase 1 (22848)
Phase 2 (32243)
Phase 3 (24059)
Pipeline (9592)
Policy (338)
Postmarket research (2748)
Preclinical (9753)
Press Release (67)
Prostate cancer (336)
Psychedelics (58)
Radiopharmaceuticals (352)
Rare diseases (1160)
Real estate (6375)
Recruiting (70)
Regulatory (27179)
Reports (56)
Research institute (2587)
Resumes & cover letters (370)
Rett syndrome (42)
RNA editing (23)
RSV (91)
Schizophrenia (189)
Series A (306)
Series B (226)
Service/supplier (12)
Sickle cell disease (120)
Special edition (24)
Spinal muscular atrophy (173)
Sponsored (50)
Startups (3910)
State (2)
Stomach cancer (19)
Supply chain (136)
Tariffs (90)
The Weekly (72)
Vaccines (1180)
Venture capital (119)
Weight loss (517)
Women's health (138)
Worklife (20)
Date
Last 7 days (611)
Last 30 days (2781)
Last 365 days (31025)
2026 (15340)
2025 (30913)
2024 (36117)
2023 (41151)
2022 (52394)
2021 (57106)
2020 (55917)
2019 (48806)
2018 (36957)
2017 (33762)
2016 (33589)
2015 (39620)
2014 (33354)
2013 (28627)
2012 (30893)
2011 (31592)
2010 (29969)
Location
Africa (823)
Alabama (95)
Alaska (7)
Arizona (373)
Arkansas (16)
Asia (43139)
Australia (7120)
California (13941)
Canada (3912)
China (1509)
Colorado (608)
Connecticut (626)
Delaware (432)
Europe (94336)
Florida (2082)
Georgia (451)
Hawaii (3)
Idaho (67)
Illinois (1185)
India (94)
Indiana (632)
Iowa (23)
Japan (583)
Kansas (136)
Kentucky (53)
Louisiana (59)
Maine (76)
Maryland (1693)
Massachusetts (10055)
Michigan (385)
Minnesota (772)
Mississippi (7)
Missouri (150)
Montana (33)
Nebraska (29)
Nevada (151)
New Hampshire (90)
New Jersey (3685)
New Mexico (32)
New York (3663)
North Carolina (1836)
North Dakota (9)
Northern California (7021)
Ohio (417)
Oklahoma (24)
Oregon (42)
Pennsylvania (2772)
Puerto Rico (29)
Rhode Island (53)
South America (1203)
South Carolina (88)
South Dakota (2)
Southern California (5512)
Tennessee (225)
Texas (2251)
United States (49571)
Utah (413)
Vermont (1)
Virginia (339)
Washington D.C. (84)
Washington State (1142)
West Virginia (4)
Wisconsin (142)
Wyoming (2)
772,376 Results for "ela medical inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Electra Therapeutics Announces First Patient Dosed in Phase 1 Study of Ipsoprubart (ELA026) in T Cell Malignancies
May 5, 2026
·
4 min read
Press Releases
Electra Therapeutics Presents SURPASS Pivotal ELA026 Study Design and Highlights the Critical Unmet Need in Secondary Hemophagocytic Lymphohistiocytosis (sHLH) at the ASH 2025 Annual Meeting
December 3, 2025
·
4 min read
Press Releases
Electra Therapeutics Receives FDA Breakthrough Therapy and EMA Priority Medicines Designations for ELA026 in Secondary Hemophagocytic Lymphohistiocytosis (sHLH)
October 23, 2025
·
3 min read
Press Releases
Electra Therapeutics Announces First Patients Dosed in the SURPASS Phase 2/3 Pivotal Study of ELA026 in Secondary Hemophagocytic Lymphohistiocytosis (sHLH)
October 23, 2025
·
4 min read
Press Releases
Novanta Inc. Announces Acquisition of Riverpoint Medical
June 9, 2026
·
12 min read
Press Releases
Inspire Medical Systems, Inc. to Participate in the Wells Fargo 2026 MedTech Innovation Spotlight
June 12, 2026
·
1 min read
Drug Development
Electra Therapeutics Presents Late-Breaking Clinical Data at EHA2024 from Ongoing Phase 1b Study of ELA026 in Secondary Hemophagocytic Lymphohistiocytosis (sHLH)
Electra Therapeutics, Inc., a clinical stage biotechnology company developing antibody therapies against novel targets for immunological diseases and cancer, announced the presentation of clinical data for ELA026 in secondary hemophagocytic lymphohistiocytosis, a life-threatening hyperinflammatory condition.
June 16, 2024
·
5 min read
Press Releases
Medical Care Technologies Inc. (OTC Pink:MDCE) Expands AI Commercialization Strategy with Enterprise Vision Solutions
May 11, 2026
·
2 min read
Press Releases
Tenon Medical, Inc. Sets Date for First Quarter 2026 Earnings
May 1, 2026
·
2 min read
Biotech Bay
Electra Therapeutics to Present ELA026 Clinical Data in Late-Breaking Oral Session at the 2024 European Hematology Association (EHA) Congress
Electra Therapeutics, Inc., a clinical stage biotechnology company developing antibody therapies against novel targets for a broad range of immunological diseases and cancer, announced today that clinical data for its lead drug candidate, ELA026, will be presented as one of five selected abstracts in a late-breaking oral session at the European Hematology Association (EHA) Congress.
June 3, 2024
·
2 min read
1 of 77,238
Next
